Johnson & Johnson Archives

J&J’s Tremfya outperforms Novartis’ Cosentyx in psoriasis

https://pharmaphorum.com/news/jjs-tremfya-outperforms-novartis-cosentyx-in-psoriasis/

J&J shares fall after court refuses to block Zytiga generics

https://pharmaphorum.com/news/jj-shares-fall-after-court-refuses-to-block-zytiga-generics/

The future of pharma in a digital world

https://pharmaphorum.com/digital/healthlive-the-future-of-pharma-in-a-digital-world/

J&J buys novel lung cancer drug from South Korea’s Yuhan

https://pharmaphorum.com/news/jj-buys-novel-lung-cancer-drug-from-south-koreas-yuhan/

Bayer plans filings for prostate cancer drug darolutamide

https://pharmaphorum.com/news/bayer-plans-filings-for-prostate-cancer-drug-darolutamide/

EU regulators review Janssen’s esketamine nasal spray antidepressant

https://pharmaphorum.com/news/eu-regulators-review-janssens-esketamine-nasal-spray-antidepressant/

Pharma depriving developing countries of taxes – report

https://pharmaphorum.com/news/pharma-depriving-developing-countries-of-taxes-report/

https://pharmaphorum.com/news/jj-trumpets-new-data-from-tremfya-as-psoriasis-market-braces-for-biosimilars/

J&J files esketamine nasal spray antidepressant in US

https://pharmaphorum.com/news/jj-files-esketamine-nasal-spray-antidepressant-in-us/

Search